Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.

MLA

Dabaja, B. S., et al. “Fractionated Cyclophosphamide, Vincristine, Liposomal Daunorubicin (DaunoXome), and Dexamethasone (HyperCVXD) Regimen in Richter’s Syndrome.” Leukemia & Lymphoma, vol. 42, no. 3, July 2001, pp. 329–37. EBSCOhost, https://doi.org/10.3109/10428190109064589.

APA

Dabaja, B. S., O’Brien, S. M., Kantarjian, H. M., Cortes, J. E., Thomas, D. A., Albitar, M., Schlette, E. S., Faderl, S., Sarris, A., Keating, M. J., & Giles, F. J. (2001). Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter’s syndrome. Leukemia & Lymphoma, 42(3), 329–337. https://doi.org/10.3109/10428190109064589

Chicago

Dabaja, B S, S M O’Brien, H M Kantarjian, J E Cortes, D A Thomas, M Albitar, E S Schlette, et al. 2001. “Fractionated Cyclophosphamide, Vincristine, Liposomal Daunorubicin (DaunoXome), and Dexamethasone (HyperCVXD) Regimen in Richter’s Syndrome.” Leukemia & Lymphoma 42 (3): 329–37. doi:10.3109/10428190109064589.